Article

June is Cataract Awareness Month

Prevent Blindness America (PBA) has declared June as Cataract Awareness Month in an effort to educate the public on the risk factors, symptoms, and treatment options of the world?s leading cause of blindness.

Chicago-Prevent Blindness America (PBA) has declared June as Cataract Awareness Month in an effort to educate the public on the risk factors, symptoms, and treatment options of the world’s leading cause of blindness.

According to PBA, there are more cases of cataract globally than there are of glaucoma, age-related macular degeneration, and diabetic retinopathy combined. Today, cataract affects more than 22 million Americans aged 40 and older. As the U.S. population ages, more than 30.1 million Americans are projected to have cataracts by the year 2020.

Risk factors for developing cataract include a family history of cataract, diabetes, smoking, extended exposure to UV rays, serious eye injury, and the use of steroids.

Americans spend $6.8 billion every year on direct medical costs for outpatient, inpatient, and prescription drug services for cataracts, according to “Economic Impact of Vision Problems: The Toll of Major Adult Eye Disorders, Visual Impairment, and Blindness on the U.S. Economy,” a 2007 study funded by PBA.

“We encourage everyone, especially those age 40 and over, to get a dilated, baseline eye exam from [their] eye care professional,” said Hugh R. Parry, PBA’s president and CEO.

PBA offers free information on cataracts in both English and Spanish, as well as the fact sheets Your Guide to Cataract Surgery and Medicare Benefits and Your Eyes. Call 800/331-2020 or visit www.preventblindness.org.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.